Other as yet unreported D2HGDH inactivating alleles may explain why a few other IDH1/2 WT AML patients displayed elevated plasma concentrations of both 2R-HG and 2,3-DHBA. This evidence concerns the gene IDH1 and acute myeloid leukemia.